NZ184735A - Peptides and pharmaceutical compositions - Google Patents

Peptides and pharmaceutical compositions

Info

Publication number
NZ184735A
NZ184735A NZ184735A NZ18473577A NZ184735A NZ 184735 A NZ184735 A NZ 184735A NZ 184735 A NZ184735 A NZ 184735A NZ 18473577 A NZ18473577 A NZ 18473577A NZ 184735 A NZ184735 A NZ 184735A
Authority
NZ
New Zealand
Prior art keywords
peptides
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
NZ184735A
Inventor
B A Morgan
S Wilkinson
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB31194/76A external-priority patent/GB1577115A/en
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of NZ184735A publication Critical patent/NZ184735A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NZ184735A 1976-07-27 1977-07-25 Peptides and pharmaceutical compositions NZ184735A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB31194/76A GB1577115A (en) 1976-07-27 1976-07-27 Container closure units
GB4882176 1976-11-23
GB524777 1977-02-09

Publications (1)

Publication Number Publication Date
NZ184735A true NZ184735A (en) 1980-05-08

Family

ID=27254606

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ184735A NZ184735A (en) 1976-07-27 1977-07-25 Peptides and pharmaceutical compositions

Country Status (8)

Country Link
JP (1) JPS5325537A (en)
AU (1) AU2727977A (en)
DE (1) DE2732451A1 (en)
DK (1) DK326477A (en)
LU (1) LU77838A1 (en)
NL (1) NL7708225A (en)
NZ (1) NZ184735A (en)
SE (1) SE7708486L (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178001B (en) * 1976-09-16 1982-02-28 Gyogyszekutato Intezet Process for preparing new pentapeptides with morphine-like activity and derivatives thereof
US4264491A (en) * 1977-10-03 1981-04-28 Eli Lilly And Company Analgesic compounds
JPS55118444A (en) * 1979-03-07 1980-09-11 Takeda Chem Ind Ltd Tetrapeptide derivative
US4261883A (en) * 1979-07-09 1981-04-14 The Regents Of The University Of California Novel N-aralkyl enkephalin amide analogs are provided having analgesic and opioid properties
DE2933947A1 (en) * 1979-08-22 1981-03-12 Hoechst Ag, 6000 Frankfurt NEW PEPTIDAMIDES AND METHOD FOR THEIR PRODUCTION.
US4273704A (en) * 1979-12-03 1981-06-16 G. D. Searle & Co. N-Adamantane-substituted tetrapeptide amides
JPS5756447A (en) * 1980-07-17 1982-04-05 Sandoz Ag Novel pentapeptides
EP0076557B1 (en) * 1981-06-22 1985-11-13 Imperial Chemical Industries Plc Peptides and pseudopeptides in which the n terminus bears two substituents
US4407746A (en) * 1981-12-14 1983-10-04 G. D. Searle & Co. Cyclohexyl and phenyl substituted enkephalins
DE3485587D1 (en) * 1983-08-16 1992-04-23 Univ Georgia Res Found PRODUCTION OF AMINOCYCLOPROPANCARBONIC ACIDS AND PEPTIDES.

Also Published As

Publication number Publication date
DK326477A (en) 1978-01-28
AU2727977A (en) 1979-02-01
JPS5325537A (en) 1978-03-09
SE7708486L (en) 1978-01-28
LU77838A1 (en) 1978-02-02
DE2732451A1 (en) 1978-02-02
NL7708225A (en) 1978-01-31

Similar Documents

Publication Publication Date Title
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
JPS52131578A (en) Novel peptide and preparation thereof
NZ185986A (en) 2-oxa-bicyclic prostag-landins and pharmaceutical compositions
NZ185356A (en) 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
IL51332A0 (en) New peptides their preparation and pharmaceutical compositions containing them
NZ183134A (en) I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
JPS5231073A (en) Peptide and intermediate thereof
NZ187638A (en) Peptides and pharmaceutical compositions
IL52433A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them
NZ184263A (en) N-(amino-alkyl-amino)-benzamides and pharmaceutical compositions
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
NZ184735A (en) Peptides and pharmaceutical compositions
ZA773935B (en) Peptide derivatives and pharmaceutical compositions containing same
JPS5362834A (en) Pharmaceutical composition and use thereof
IL52409A (en) 5-m-tolyloxyuracil and pharmaceutical compositions containing it
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
PH12590A (en) 4a-aryl octahydro-1h-2-pyrindines and pharmaceutical composition thereof
JPS5320433A (en) Pharmaceutical composition and application
IL52528A0 (en) New peptide derivatives their manufacture and pharmaceutical compositions containing them
NZ185341A (en) 19-oxygenated steroids and pharmaceutical compositions
NZ185296A (en) Corticoids and pharmaceutical compositions
NZ183756A (en) Bis-penicillanoyloxy-alkanes and pharmaceutical compositions